i'm thinking (hoping) the Q1 of next year HIV BLA timeline is conservative - and it gets submitted earlier in the quarter vs. later. Given all the heat that management has taken for this whole BLA debacle, you would think they would want to under-promise / over-deliver at this point. Put another way, if they don't hit Q1 of next year, the #$%& will hit the fan - and they know that - so hopefully they think they can get it done in Jan - but provided some cushion in the form of "Q1 of 2022". Don't know if others feel this way.

Come on NASH data - sure would be a nice stocking stuffer to have some irrefutably fantastic data. Whether it moves the SP or not, you would think it positions us for a killer partnership - which will move the data.